相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans
Leonard Both et al.
FASEB JOURNAL (2013)
Intracellular Reprogramming of Expression, Glycosylation, and Function of a Plant-Derived Antiviral Therapeutic Monoclonal Antibody
Jeong-Hwan Lee et al.
PLOS ONE (2013)
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
Leonard Both et al.
VACCINE (2013)
Passive immunity in the prevention of rabies
Leonard Both et al.
LANCET INFECTIOUS DISEASES (2012)
Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults
Nithya Gogtay et al.
VACCINE (2012)
Antibody degradation in tobacco plants: a predominantly apoplastic process
Verena K. Hehle et al.
BMC BIOTECHNOLOGY (2011)
Molecular pharming Future targets and aspirations
Mathew Paul et al.
HUMAN VACCINES (2011)
Emerging antibody products and Nicotiana manufacturing
Kevin J. Whaley et al.
HUMAN VACCINES (2011)
Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice
Ada Triguero et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
Quantifying Antigenic Relationships among the Lyssaviruses
D. L. Horton et al.
JOURNAL OF VIROLOGY (2010)
The fight against rabies in Africa: From recognition to action
Betty Dodet
VACCINE (2009)
Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
Thomas Mueller et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Novel Vaccines to Human Rabies
Hildegund C. J. Ertl
PLOS NEGLECTED TROPICAL DISEASES (2009)
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma:: Safety and immunogenicity in a phase I clinical study
A. A. McCormick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides
Johannes Stadlmann et al.
PROTEOMICS (2008)
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
A. B. H. Bakker et al.
VACCINE (2008)
Rabies Exposures, Post-Exposure Prophylaxis and Deaths in a Region of Endemic Canine Rabies
Katie Hampson et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies
Kader Muhamuda et al.
HUMAN VACCINES (2007)
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates
Susan E. Sloan et al.
VACCINE (2007)
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin
J Goudsmit et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses
SM Brookes et al.
VACCINE (2005)
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants
ABH Bakker et al.
JOURNAL OF VIROLOGY (2005)
Prophylaxis against rabies
CE Rupprecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies
M Prosniak et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Function and glycosylation of plant-derived antiviral monoclonal antibody
KS Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges
T Hemachudha et al.
LANCET NEUROLOGY (2002)
Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis
CA Hanlon et al.
VACCINE (2001)
Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity
H Badrane et al.
JOURNAL OF VIROLOGY (2001)
The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure
JM Champion et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
分享论文
